Royal Bank of Canada’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,359
Closed -$66K 7116
2016
Q4
$66K Sell
2,359
-75
-3% -$2.1K ﹤0.01% 5100
2016
Q3
$67K Sell
2,434
-1,412
-37% -$38.9K ﹤0.01% 5023
2016
Q2
$85K Sell
3,846
-3,866
-50% -$85.4K ﹤0.01% 4862
2016
Q1
$173K Buy
7,712
+283
+4% +$6.35K ﹤0.01% 4460
2015
Q4
$206K Buy
7,429
+1,604
+28% +$44.5K ﹤0.01% 4499
2015
Q3
$150K Sell
5,825
-309
-5% -$7.96K ﹤0.01% 4522
2015
Q2
$153K Buy
6,134
+2,012
+49% +$50.2K ﹤0.01% 4564
2015
Q1
$104K Sell
4,122
-22,718
-85% -$573K ﹤0.01% 4606
2014
Q4
$630K Sell
26,840
-18,356
-41% -$431K ﹤0.01% 3344
2014
Q3
$1.03M Buy
45,196
+33,625
+291% +$766K ﹤0.01% 2820
2014
Q2
$283K Sell
11,571
-4,540
-28% -$111K ﹤0.01% 3913
2014
Q1
$340K Sell
16,111
-673
-4% -$14.2K ﹤0.01% 3655
2013
Q4
$399K Buy
16,784
+11,880
+242% +$282K ﹤0.01% 3602
2013
Q3
$105K Sell
4,904
-6,635
-58% -$142K ﹤0.01% 4456
2013
Q2
$229K Buy
+11,539
New +$229K ﹤0.01% 3788

Other funds holding QGENF

Royal Bank of Canada's QGENF Position: Q1 2017 in Review

Royal Bank of Canada sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 2,359 shares — an estimated $66K sold.

Royal Bank of Canada first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $1.03M in Q3 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Royal Bank of Canada reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 2,359 QIAGEN NV shares in Q1 2017, an estimated $66K.
  • Royal Bank of Canada first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Royal Bank of Canada's QIAGEN NV position peaked at $1.03M in Q3 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Royal Bank of Canada's 13F filing for Q1 2017, filed 15 May 2017.